EUVIMEDEUVIMED entdecken
Crossref

Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy

Ikram U Haq, Nadia Akhiyat, Nader Al-Shakarchi, Konstantinos C Siontis, Siva K Mulpuru, Alan Sugrue, John Giudicessi, Paul A Friedman, Samuel J Asirvatham, Ammar M Killu

JACC: Clinical Electrophysiology · 2024-07 · 10 (7) · 1380-1391

DOI: 10.1016/j.jacep.2024.03.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2024-07. Verfasst von Ikram U Haq und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: https://twitter.com/IkramHaqMD. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Carrier Proteins, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The effects of disease-causing MYBPC3 or MYH7 genetic variants on atrial myopathy, atrial fibrillation (AF) clinical course, and catheter ablation efficacy remain unclear. OBJECTIVES: The aim of this study was to characterize the atrial substrate of patients with MYBPC3- or MYH7-mediated hypertrophic cardiomyopathy (HCM) and its impact on catheter ablation outcomes. METHODS: A retrospective single-center study of patients with HCM who underwent genetic testing and catheter ablation for AF was performed. Patients with MYBPC3- or MYH7-mediated HCM formed the gene-positive cohort; those without disease-causative genetic variants formed the control cohort. High-density electroanatomical mapping was performed using a 3-dimensional mapping system, followed by radiofrequency ablation. RESULTS: Twelve patients were included in the gene-positive cohort (mean age 55.6 ± 9.9 years, 83% men, 50% MYBPC3, 50% MYH7, mean ejection fraction 59.3% ± 13.7%, mean left atrial [LA] volume index 51.7 ± 13.1 mL/m2, mean LA pressure 20.2 ± 5.4 mm Hg) and 15 patients in the control arm (mean age 61.5 ± 12.6 years, 60% men, mean ejection fraction 64.9% ± 5.1%, mean LA volume index 54.1 ± 12.8 mL/m2, mean LA pressure 19.6 ± 5.41 mm Hg). Electroanatomical mapping demonstrated normal voltage in 87.7% ± 5.03% of the LA in the gene-positive cohort and 94.3% ± 3.58% of the LA in the control cohort (P < 0.001). Of the abnormal regions, intermediate scar (0.1-0.5 mV) accounted for 6.33% ± 1.97% in the gene-positive cohort and 3.07% ± 2.46% in the control cohort (P < 0.01). Dense scar (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationCarrier ProteinsCardiomyopathy, HypertrophicMyosin Heavy ChainsCardiac MyosinsHumansMiddle AgedFemaleMaleRetrospective StudiesAgedAdultTreatment OutcomeMyosin Binding Protein C

Stichwörter der Autor:innen

HCMablationatrial fibrillation

Substanzen

Carrier ProteinsMyosin Heavy ChainsCardiac MyosinsMyosin Binding Protein CMYH7 protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: https://twitter.com/IkramHaqMD.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: killu.ammar@mayo.edu.

Zitieren

APA

Haq, I. U., Akhiyat, N., Al-Shakarchi, N., Siontis, K. C., Mulpuru, S. K., Sugrue, A., Giudicessi, J., Friedman, P. A., Asirvatham, S. J., & Killu, A. M. (2024). Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology, 10(7), 1380-1391. https://doi.org/10.1016/j.jacep.2024.03.026

Vancouver

Haq IU, Akhiyat N, Al-Shakarchi N, Siontis KC, Mulpuru SK, Sugrue A, et al. Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology. 2024;10(7):1380-1391. doi:10.1016/j.jacep.2024.03.026

BibTeX
@article{Haq2024,
  author = {Haq, Ikram U and Akhiyat, Nadia and Al-Shakarchi, Nader and Siontis, Konstantinos C and Mulpuru, Siva K and Sugrue, Alan and Giudicessi, John and Friedman, Paul A and Asirvatham, Samuel J and Killu, Ammar M},
  title = {Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {7},
  pages = {1380--1391},
  doi = {10.1016/j.jacep.2024.03.026}
}
Kostenlos starten →